Daiwa Securities Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2K | Hold |
215
| – | – | ﹤0.01% | 1229 |
|
|
2025
Q1 | $2K | Hold |
215
| – | – | ﹤0.01% | 1198 |
|
|
2024
Q4 | $2K | Hold |
215
| – | – | ﹤0.01% | 1233 |
|
|
2024
Q3 | $2K | Buy |
215
+200
| +1,333% | +$1.86K | ﹤0.01% | 1234 |
|
|
2024
Q2 | $0 | Sell |
15
-200
| -93% | – | ﹤0.01% | 1358 |
|
|
2024
Q1 | $2K | Hold |
215
| – | – | ﹤0.01% | 1270 |
|
|
2023
Q4 | $2K | Hold |
215
| – | – | ﹤0.01% | 1273 |
|
|
2023
Q3 | $2K | Hold |
215
| – | – | ﹤0.01% | 1221 |
|
|
2023
Q2 | $2K | Hold |
215
| – | – | ﹤0.01% | 1239 |
|
|
2023
Q1 | $2K | Hold |
215
| – | – | ﹤0.01% | 1218 |
|
|
2022
Q4 | $2K | Hold |
215
| – | – | ﹤0.01% | 1233 |
|
|
2022
Q3 | $2K | Hold |
215
| – | – | ﹤0.01% | 1241 |
|
|
2022
Q2 | $2K | Hold |
215
| – | – | ﹤0.01% | 1243 |
|
|
2022
Q1 | $2K | Hold |
215
| – | – | ﹤0.01% | 1264 |
|
|
2021
Q4 | $2K | Buy |
215
+95
| +79% | +$884 | ﹤0.01% | 1292 |
|
|
2021
Q3 | $1K | Hold |
120
| – | – | ﹤0.01% | 1279 |
|
|
2021
Q2 | $2K | Hold |
120
| – | – | ﹤0.01% | 1155 |
|
|
2021
Q1 | $2K | Hold |
120
| – | – | ﹤0.01% | 1162 |
|
|
2020
Q4 | $2K | Sell |
120
-228
| -66% | -$3.8K | ﹤0.01% | 1138 |
|
|
2020
Q3 | $5K | Hold |
348
| – | – | ﹤0.01% | 1086 |
|
|
2020
Q2 | $32K | Hold |
348
| – | – | ﹤0.01% | 967 |
|
|
2020
Q1 | $8K | Buy |
348
+28
| +9% | +$644 | ﹤0.01% | 1065 |
|
|
2019
Q4 | $7K | Sell |
320
-33
| -9% | -$722 | ﹤0.01% | 1079 |
|
|
2019
Q3 | $7K | Hold |
353
| – | – | ﹤0.01% | 1044 |
|
|
2019
Q2 | $6K | Hold |
353
| – | – | ﹤0.01% | 1068 |
|
|
2019
Q1 | $8K | Buy |
+353
| New | +$8K | ﹤0.01% | 1034 |
|
|
2018
Q4 | – | Sell |
-299
| Closed | -$10K | – | 1167 |
|
|
2018
Q3 | $10K | Hold |
299
| – | – | ﹤0.01% | 1025 |
|
|
2018
Q2 | $7K | Hold |
299
| – | – | ﹤0.01% | 1063 |
|
|
2018
Q1 | $7K | Buy |
+299
| New | +$7K | ﹤0.01% | 1048 |
|